2023
DOI: 10.17650/1818-8346-2023-18-4-233-243
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticosteroid-induced complications in patients with idiopathic thrombocytopenic purpura

S. G. Zakharov,
T. A. Mitina,
A. V. Zakharova
et al.

Abstract: Glucocorticosteroids (GCS) are the first-line treatment for idiopathic thrombocytopenic purpura (ITP). Despite their high efficacy in patients with newly diagnosed ITP, an adequate level of platelets remains after GCS withdrawal in only less than 20 % of patients. Additionally, GCS use is associated with an increased risk of different adverse reactions, including serious and life-threatening ones. Thrombopoietin receptor agonists represent a relatively new class of drugs for treating ITP as a second-line thera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 60 publications
0
0
0
Order By: Relevance